DERM - CIK 0001867066
Journey Medical Corp (DERM) reported net income of -$11.43M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$11.43M | +22.1% |
| FY 2024 | -$14.67M | -280.8% |
| FY 2023 | -$3.85M | +87.0% |
| FY 2022 | -$29.63M | +32.7% |
| FY 2021 | -$43.99M | -932.7% |
| FY 2020 | $5.28M | - |
Journey Medical Corp (DERM) reported net income of -$11.43M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Journey Medical Corp's net income declined from $5.28M to -$11.43M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.